Showing results (151-160 of 299) with videos related to
Sort By:
Pageof 30
International Journal of Cardiology|July 27, 2013
Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapyChris T Longenecker, Ying Jiang, Chun-Ho Yun, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2012
HIV-1 is not a major driver of increased plasma IL-6 levels in chronic HIV-1 diseaseCarey L Shive, Angélique Biancotto, Nicholas T Funderburg, et al.Journal of the National Cancer Institute|May 16, 2002
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East AfricaMwanda W Otieno, Cecily Banura, Edward Katongole-Mbidde, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapyScott L Butler, Hernan Valdez, Michael Westby, et al.AIDS (London, England)|April 3, 2014
Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infectionChris T Longenecker, Ying Jiang, Carl E Orringer, et al.Frontiers in Immunology|October 25, 2021
Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green MonkeysCeleste Coleman, Lara A Doyle-Meyers, Kasi E Russell-Lodrigue, et al.Ebiomedicine|March 17, 2016
Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International StudyLaura W Musselwhite, Bruno B Andrade, Susan S Ellenberg, et al.AIDS (London, England)|June 24, 2003
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatmentMireya Diaz, Daniel C Douek, Hernan Valdez, et al.Journal of Virology|August 21, 2009
Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell functionSara J Conry, Kimberly A Milkovich, Nicole L Yonkers, et al.The Journal of Infectious Diseases|July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core proteinRobert T Schooley, John Spritzler, Hongying Wang, et al.Pageof 30